FDA Clears Diagnostic Hybrids Viral ID Test | GenomeWeb

NEW YORK (GenomeWeb News) – The US Food and Drug Administration has cleared Diagnostic Hybrids' respiratory viral identification kit for use in the US, the company said Tuesday.

Diagnostic Hybrids, which is based in Athens, Ohio, said that the FDA has cleared its D3 Fastpoint L-DFA RSV/MPV Identification kit.

The kit allows for the identification of respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) in less than 25 minutes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.